The effects of combined treatment using paclitaxel and zoledronic acid on tumour cells and endothelial cells in vitro

Haematologica Reports

Volumn 2, Issue 3, 2006, Pages 48-49

  Michailidou, M ^a   Neville Webbe, H L ^a   Woodward, J K ^a   Lefley, D V ^a   Brown, N J ^a   Coleman, R E ^a   Holen, I ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; ZOLEDRONIC ACID;

BREAST CANCER; CELL DEATH; CONFERENCE PAPER; DRUG EFFECT; DRUG POTENTIATION; ENDOTHELIUM CELL; HUMAN; IN VITRO STUDY; TUMOR CELL;

EID: 46749101397     PISSN: 18249337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Neville-Webbe HL, Holen I, Coleman RE. The antitumour effect of bisphosphonates Cancer Treatment Reviews 2002;28:305-19.
2. Neville-Webbe HL, Evans CA, Coleman RE and Holen I (2005). Mechanisms of the synergistic interaction between the bisphosphonate Zoledronic Acid and the chemotherapy agents Paclitaxel in breast cancer cells in vitro. Tumor Biology, In press.